As a national medicine shortage worsens, Lipitor (atorvastatin) — a statin medication used to prevent cardiovascular disease in high-risk cases, as well as abnormal lipid levels — has been among hardest to source. Minister of Health and Welfare Hsueh Jui-yuan (薛瑞元) has said that the shortage would not put citizens’ health in jeopardy, as there are other generic drugs that offer the same effect.
The National Health Insurance Administration has been promoting the “same ingredients, same dosage form, same component” policy for years. The problem is that people still fall victim to media hype whenever there are reports of a shortage of a single brand of drug, forcing the government to repeatedly clarify the issue. If people can learn to regard generic drugs as an alternative to brand-name medicines, there would be a lot less confusion and commotion.
The Federation of Taiwan Pharmacists’ Associations once conducted an online poll, with only half of the participants saying they supported the administration’s policy.
Asked if the statement “I would not go the community pharmacy for drugs over concerns that the prescription drug on offer is not a brand-name drug” applied to them, only 40 percent of participants said that they had never had this concern.
Despite pharmacists’ efforts to convince customers that generic drugs are not counterfeit and are alternative medications developed by other companies that offer the same effect as brand-name drugs, people are still unable to shake off their bias and fixed perceptions. This herd mentality not only causes meaningless panic, but hinders Taiwan’s development of generic drugs.
While generic drugs account for the majority of Taiwan’s pharmaceutical manufacturing industry, generics overall account for nearly 70 percent of the quantity, but less than 30 percent of the cost of items covered by the National Health Insurance.
It goes without saying that without demand, local drug companies would not pour more resources into research and development, leaving the generic drug industry to stagnate.
Taiwan became a member of the Pharmaceutical Inspection Convention and Co-operation Scheme in 2015, indicating that Taiwan’s manufactured drugs meet the global standard.
Under the promotion of the Federation of Taiwan Pharmacists’ Associations and the collaboration of hospitals and institutions, most of the refillable prescriptions for patients with chronic illnesses are no longer labeled as “noninterchangeable.”
However, there are still cases in which hospitals have told patients that they have prescribed them “brand-name drugs,” giving people the false impression that they were given medication of superior quality.
Hsueh hit the nail on the head when he said that it is not true when people claim they are not used to generic drugs. Nonetheless, other than relying on pharmacists to teach the public about efficacy of generic medication, the government should create resources and systematically teach the public about generic drugs.
The government should step up its supervision of hospitals. In countries such as Canada, the UK and the US, pharmacists have to list the ingredients of the drug on prescriptions to avoid patients misunderstanding them.
Even though it is a Herculean task to educate the public, peoples’ misconceptions about generic drugs have influenced the drug manufacturing industry and the National Health Insurance system. Only by implementing reforms can the government clear the stigma of generic drugs, enhance the development of the industry and improve citizens’ medication welfare.
Huang Jin-shun is president of the Federation of Taiwan Pharmacists’ Associations.
Translated by Rita Wang
In their recent op-ed “Trump Should Rein In Taiwan” in Foreign Policy magazine, Christopher Chivvis and Stephen Wertheim argued that the US should pressure President William Lai (賴清德) to “tone it down” to de-escalate tensions in the Taiwan Strait — as if Taiwan’s words are more of a threat to peace than Beijing’s actions. It is an old argument dressed up in new concern: that Washington must rein in Taipei to avoid war. However, this narrative gets it backward. Taiwan is not the problem; China is. Calls for a so-called “grand bargain” with Beijing — where the US pressures Taiwan into concessions
The term “assassin’s mace” originates from Chinese folklore, describing a concealed weapon used by a weaker hero to defeat a stronger adversary with an unexpected strike. In more general military parlance, the concept refers to an asymmetric capability that targets a critical vulnerability of an adversary. China has found its modern equivalent of the assassin’s mace with its high-altitude electromagnetic pulse (HEMP) weapons, which are nuclear warheads detonated at a high altitude, emitting intense electromagnetic radiation capable of disabling and destroying electronics. An assassin’s mace weapon possesses two essential characteristics: strategic surprise and the ability to neutralize a core dependency.
Chinese President and Chinese Communist Party (CCP) Chairman Xi Jinping (習近平) said in a politburo speech late last month that his party must protect the “bottom line” to prevent systemic threats. The tone of his address was grave, revealing deep anxieties about China’s current state of affairs. Essentially, what he worries most about is systemic threats to China’s normal development as a country. The US-China trade war has turned white hot: China’s export orders have plummeted, Chinese firms and enterprises are shutting up shop, and local debt risks are mounting daily, causing China’s economy to flag externally and hemorrhage internally. China’s
During the “426 rally” organized by the Chinese Nationalist Party (KMT) and the Taiwan People’s Party under the slogan “fight green communism, resist dictatorship,” leaders from the two opposition parties framed it as a battle against an allegedly authoritarian administration led by President William Lai (賴清德). While criticism of the government can be a healthy expression of a vibrant, pluralistic society, and protests are quite common in Taiwan, the discourse of the 426 rally nonetheless betrayed troubling signs of collective amnesia. Specifically, the KMT, which imposed 38 years of martial law in Taiwan from 1949 to 1987, has never fully faced its